Bonus BioGroup Ltd. Stock price

Equities

BONS

IL0004850116

Biotechnology & Medical Research

Market Closed - TEL AVIV STOCK EXCHANGE 11:24:58 2024-03-28 am EDT 5-day change 1st Jan Change
21.4 ILa -0.47% Intraday chart for Bonus BioGroup Ltd. -2.73% +28.14%
Sales 2021 - Sales 2022 - Capitalization 224M 82.46B
Net income 2021 -90M -33.1B Net income 2022 -38M -13.97B EV / Sales 2021 -
Net cash position 2021 67.2M 24.71B Net cash position 2022 41.67M 15.32B EV / Sales 2022 -
P/E ratio 2021
-16.1 x
P/E ratio 2022
-5.79 x
Employees 57
Yield 2021 *
-
Yield 2022
-
Free-Float 54.94%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.47%
1 week-2.73%
Current month-13.71%
1 month-4.46%
3 months+27.38%
6 months+32.10%
Current year+28.14%
More quotes
1 week
20.80
Extreme 20.8
23.00
1 month
20.00
Extreme 20
26.80
Current year
16.50
Extreme 16.5
32.00
1 year
14.10
Extreme 14.1
32.00
3 years
13.90
Extreme 13.9
175.00
5 years
13.90
Extreme 13.9
175.00
10 years
13.90
Extreme 13.9
175.00
More quotes
Managers TitleAgeSince
Founder 55 12-04-28
Director of Finance/CFO 49 14-05-31
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Founder 55 12-04-28
Director/Board Member 73 20-09-28
Director/Board Member 65 12-04-28
More insiders
Date Price Change Volume
24-03-28 21.4 -0.47% 1,193,970
24-03-27 21.5 -3.15% 1,194,305
24-03-26 22.2 -1.77% 1,091,883
24-03-25 22.6 +2.73% 1,477,875
24-03-21 22 +1.85% 2,018,399

Delayed Quote TEL AVIV STOCK EXCHANGE, March 28, 2024 at 11:24 am EDT

More quotes
Bonus Biogroup Ltd, formerly Oceana Advanced Industries Ltd, is an Israel-based product-focused biotechnology company applying technology for supplying bone regeneration tissues. The Company is developing cell therapy products based on autologous and allogeneic bone implants that will enable efficient bone transplant and provide cellular-based bone replacement prosthetics for repairing bone lesions. It is targeting a worldwide market for the treatment of major disorders such as bone and cartilage related arthritis, osteoporosis, and various types of bones and joint trauma such as hip fractures and knee injuries, among others. On April 29, 2012, Bonus Bio Group Ltd fully acquired Bonus Therapeutic Ltd.
More about the company
  1. Stock
  2. Equities
  3. Stock Bonus BioGroup Ltd. - TEL AVIV STOCK EXCHANGE